Scientific Program
Opening Lectures
-
THE ROLE OF KIS PEPTIDES IN THE REGULATION OF THE OVULATORY CYCLE
- Lunenfeld Bruno (IL) The role of kis peptides in the regulation of the ovulatory cycle
Plenary Lectures
-
(PL01) HUMAN UTERUS TRANSPLANTATION WITH LIVEBIRTHS
- Braennstroem Mats (SE) Human uterus transplantation with livebirths
-
(PL02) PERSONALIZED MEDICINE FOR MENOPAUSE: WHERE ARE WE IN 2016?
- Santen Richard J. (US) Personalized medicine for menopause: where are we in 2016?
-
(PL03) ANOREXIA NERVOSA: NEW DEVELOPMENTS IN ENDOCRINOLOGY AND METABOLISM
- Sultan Charles (FR) Anorexia nervosa: new developments in endocrinology and metabolism
-
(PL04) FROM CORTISOL TO ESTRADIOL AND PROGESTERONE: CAN WE EFFECTIVELY MANIPULATE TISSUE CONTENT OF STEROIDS?
- Bouchard Phillipe (FR) From cortisol to estradiol and progesterone: can we effectively manipulate tissue content of steroids?
Plenary Sessions
-
(PS01) NEW INSIGHT INTO FEMALE- SPECIFIC FACTOR THAT INFLUENCE BRAIN FUNCTION
- Maki Pauline (US) The link between vasomotor symptoms and memory decline: how strong is the evidence?
- Schagen Sanne (NL) Cognition and brain function and structure in breast cancer survivors: effects of systemic therapy
- Hunter Myra (GB) Cognitive behavior therapy as a treatment for VMS: evidence from RCTs and mechanism of action
-
(PS02) NEUROENDOCRINOLOGY : FROM BASIC SCIENCE TO CLINICAL IMPACT
- Naftolin Frederick (US) Creating positive feedback in organ culture of the rat hypothalamus
- Bouchard Phillipe (FR) Hypogonadotropic hypogonadisms etiologies and applications
- Berga Sarah (US) The neuroendocrine impact of cognitive behavior therapy of stress-induced anovulation
- Maki Pauline (US) Stress responsivity in midlife women: the role of childhood trauma
-
(PS03) BREAST CANCER RISK AND HORMONES -part 1-
- Kiesel Ludwig (DE) Progestins and breast carcinogenesis
- Ruan Xiangyan (CN) Dependency on dosage, duration, regimen and type?
- Biglia Nicoletta (IT) Risk of breast cancer following fertility treatments
- Santen Richard J. (US) Can therapies for menopausal symptoms prevent breast cancer at the same time?
-
(PS04) BREAST CANCER RISK AND HORMONES -part 2-
- Mueck Alfred (DE) Preconditions of genotoxic estrogen metabolites to induce breast cancer
- Sismondi Piero (IT) Obesity, inflammation and breast cancer
- von Schoultz Bo (SE) Are androgens risk factors or protective for the breast?
- Foidart Jean Michel (BE) Endocrine sensitivity of normal and malignant breast: a concern?
-
(PS05) METABOLIC SYNDROME
- Berga Sarah (US) Stress, emotional eating, and reproduction: role of GABA
- Genazzani Alessandro D. (IT) Insulin resistance, PCOS and obesity: integrative treatments that can improve insulin sensitivity
- Chedraui Peter (EC) The metabolic syndrome after the menopause: pro-inflammation and endothelial dysfunction
- Perez-Lopez Faustino (ES) Insulin resistance and endometrial cancer
-
(PS06) SPORT AND FEMALE REPRODUCTIVE FUNCTION
- Paoletti Anna Maria (IT) Thinness and physical activity
- Sultan Charles (FR) Female athletes and bone mass acquisition: a paradox ?
- Hirschberg Angelica L. (SE) Hyperandrogenism and PCOS in female athletes: an advantage for physical performance?
-
(PS07) PCOS
- Milewicz Andrzej (PL) Serum glipikan 4 levels in women with pcos
- Fauser Bart C. (NL) PCOS: reproductive dysfunction and long-term cardiovascular health implications
- Tarlatzis Basil (GR) Can we eliminate OHSS in PCOS women undergoing ovarian stimulation for IVF ?
- Perez-Lopez Faustino (ES) Obesity and metabolic syndrome in adolescents
-
(PS08) SEXUALITY
- Castelo Branco Camil (ES) Sexuality and quality of life in congenital hypogonadisms
- Hirschberg Angelica L. (SE) Influence of oral contraceptives on sexuality: evidence from randomized
placebo-controlled trials
- Bitzer Johannes (CH) Sexual pain: how to manage ?
- Nappi Rossella (IT) Is a sexy life an healthy life at menopause?
-
(PS09) PREGNANCY AND PROGESTERONE
- Devoto Luigi (CL) Progesterone from ovulation to pregnancy
- Petraglia Felice (IT) Pregnancy at risk in women with reproductive disorders
- Schindler Adolf (DE) Type of progestogen used for treatment and prevention of pregnancy disorders and mechanisms of action
- Carp Howard (IL) Results of recent meta-analyses on progestogens in threatened and recurrent miscarriage
-
(PS10) HRT AND CARDIOVASCULAR RISK
- Lambrinoudaki Irene (GR) Managing cardio-metabolic risk after menopause
- Collins Peter (GB) Management of coronary disease in postmenopausal women
- Siseles Nestor (AR) Cardiovascular health in menopausal woman : when to begin the hormone treatment ?
- Birkhaeuser Martin (CH) Why prefer transdermal to oral menopausal hormone therapy
-
(PS11) NEUROSTEROIDS : THE BRAIN AS A TARGET
- Sitruk – Ware Regine (US) Progesterone and the brain
- Schumacher Michael (FR) Androgen and the brain
- Genazzani Andrea R. (IT) Estrogens and the brain
-
(PS12) ATHEROSCLEROSIS IN WOMEN
- Stevenson John C. (GB) Assessment of cardiovascular risk at the menopause
- Arnal Jean Francois (FR) Understanding the tissue specific action of estrogens and selective estrogen receptor modulators
- Simoncini Tommaso (IT) Role of progesterone and progestins on endothelial coagulation and fibrinolytic
pathways
-
(PS13) IVF : FROM THE PATIENTS TO THE CLINIC
- Artini Paolo G. (IT) Gene expression in cumulus cells and IVF outcome
- Gianaroli Luca (IT) NGP: new generation patients
- Barri Pedro N. (ES) PGS in IVF implantation failure
- Donnez Jaques (BE) Should we treat myomas before IVF ? If yes ,which treatment ?
-
(PS14) IVF : THE THERAPIES
- La Marca Antonio (IT) How to choose the FSH starting dose in IVF
- Imthurn Bruno (CH) Clinical and patient experience with a novel r-hFSH in IVF
- Shoham Zeev (IL) How aggressive we needs to be with luteal phase support? Progesterone, Estrogen, GnRH agonist, or hCG
- Lunenfeld Bruno (IL) Towards a hyperstimulation free clinic
-
(PS15) VITAMIN D AND BONE METABOLISM
- Milewicz Andrzej (PL) Vitamin D , Vitamine D Binding Proteine and VDR gene polymorphisms in women PCOS
- Brincat Mark (MT) A new look at Vitamin D and its pharmacological application in infertility
- Al-Azzawi Farook (GB) The clinical choice between oestrogen and bisphosphonates in the prevention of post-menopausal osteoporosis – are women being mislead ?
- Palacios Santiago (ES) New strategies in the treatment of osteoporosis
-
(PS16) RECONSTRUCTIVE SURGERY
- Creatsas George (GR) Vulvovaginal congenital anomalies
- Fedele Luigi (IT) Creation of a neovagina by Davydov’s laparoscopic modified technique in patients with
Rokitansky syndrome
- Adamyan Leila (RU) Uptodate strategy for myoma, endometriosis and adenomyosis
- Mettler Liselotte (DE) When is tubectomy and when ovariectomy indicated in benign gynecological surgery
-
(PS17) HIGH RISK PREGNANCY
- Holzgreve Wolfgang (DE) Non-invasive prenatal diagnostics from material blood – finally available in clinical practice
- Hod Moshe (IL) Towards a universal consensus on diagnosis of GDM – The FIGO GDM initiative project
- Ferrazzi Enrico M. (IT) Clinical phenotypes of pre-eclampsia
- Di Renzo Gian Carlo (IT) Prevention and management for postpartum hemorrhage in anomalies of placenta insertion
-
(PS18) OVARIAN CANCER AND ANDROGENS SECRETING
- Kenemans Peter (NL) Ovarian carcinoma in BRCA mutation carriers
- Benedetti Panici Pierluigi (IT) Conservative Surgery for the Treatment for Epitelial Ovarian Cancer
- Gadducci Angiolo (IT) Parp inhibitors in ovarian cancer
- Noelting Manuel (AR) Androgens secreting tumors
-
(PS19) DUB AND FIBROIDS
- Goldstein Steven R. (US) Diagnosis of DUB: the standard of care has changed!
- Lumsden Mary Ann (GB) Studies of the mechanism of action of UAE
- Maruo Takeshi (JP) Lessons learned from the preclinical studies with PRMs for non-surgical treatment of
uterine fibroids
- Sciarra John J. (US) New management for uterine fibroids
-
(PS20) CLINICAL TRIALS IN MENOPAUSE
- Naftolin Frederick (US) An update of studies on HRT since the WHI
- Schierbeck Louise (DK) Cardiovascular disease in postmenopausal women; does HRT have a role?
- Canonico Marianne (FR) HRT and venous thromboembolism … what differences between US and South European treatments ?
- Gompel Anne (FR) Progestins and breast cancer Risk highlights from France ?
-
(PS21) MENOPAUSE AND PERSONAL RISKS
- Cano Antonio (ES) Personalised medicine after menopause: the case of women with profiles of risk
- De Geyter Christian (CH) Effects of HRT on gene expression in breast tissue of healthy postmenopausal women
- Brincat Mark (MT) Muscolo skeletal changes in the menopause and their response to HRT
- Studd John (GB) Hormone therapy for depression and loss of libido
-
(PS22) HYPOGONADISM AND POF
- Panay Nicholas (GB) POI registry: new frontiers in global collaboration
- Ben Rafael Zion (IL) Poor ovarian reserve- what can be done?
- Meczekalski Blazej (PL) Long-term consequences of POF
- Vujovic Svetlana (RS) Premature Ovarian Failure, Transsexualism: evolutionary concept
-
(PS23) CONTRACEPTION : FROM NEEDS TO POSSIBILITIES
- De Melo Nilson R. (BR) Contraception in special situations
- Schindler Adolf (DE) Progestogen-only contraceptives: benefits and risks
- Sitruk – Ware Regine (US) Progesterone receptor modulators for contraception
- Nappi Rossella (IT) Pain threshold modulation by CHC in women with menstrually-related migraine
-
(PS24) FERTILITY PRESERVATION
- Fauser Bart C. (NL) Fertility preservation: How to balance potential benefits versus risks
- Anderson Richard A. (GB) Personalising decision making in fertility preservation
- Donnez Jaques (BE) Restoration of ovarian activity and fertility after ovarian tissue transplantion
- Benedetto Chiara (IT) Pregnancy outcomes after autologous ovarian transplantation
Meet the Experts
-
(ME01) ENDOMETRIUM
- Simon Carlos (ES) Scratch or not to Scratch?
- Goldstein Steven R. (US) Modern evaluation of the endometrium
-
(ME02) ENDOMETRIOSIS
- Petraglia Felice (IT) Mechanisms of action of medical treatments
- Kiesel Ludwig (DE) When and how to treat deep-infiltrating endometriosis prior to IVF
-
(ME03) STEM CELLS : FROM THE THERAPY TO THE PRACTICE
- Simon Carlos (ES) Stem Cell Therapy of the Endometrium in Asherman´s syndrome and atrophic endometrium
- Anderson Richard A. (GB) Ovarian Germline stem cells
http://agef.mailupclientab.com/frontend/nl_preview_window.aspx?idNL=754&fc=NzU0&source=SOCIAL